Cargando…

Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma

BACKGROUND: The potential role of the renin-angiotensin system (RAS) in the promotion of tumour growth has been investigated, and the administration of RAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs), may improve disease control in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, N, Miyajima, A, Kikuchi, E, Matsumoto, K, Hagiwara, M, Ide, H, Kosaka, T, Masuda, T, Nakamura, S, Oya, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261676/ https://www.ncbi.nlm.nih.gov/pubmed/22187036 http://dx.doi.org/10.1038/bjc.2011.565

Ejemplares similares

Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2022)

Localisation of renin-angiotensin system (RAS) components in breast
por: Tahmasebi, M, et al.
Publicado: (2006)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma
por: Ide, Hiroki, et al.
Publicado: (2012)

Visceral to total obesity ratio and severe hydronephrosis are independently associated with prolonged pneumoperitoneum operative time in patients undergoing laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2015)

Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
por: Yoshimine, S, et al.
Publicado: (2013)

Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
por: Ravid, Mordchai
Publicado: (2009)

Renin–angiotensin system blockade for the risk of cancer and death
por: Shen, Jian, et al.
Publicado: (2016)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Left ventricular hypertrophy and renin-angiotensin system blockade
por: Cowan, Brett R., et al.
Publicado: (2009)

Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021)

Prognostic significance of the albumin-to-globulin ratio for upper tract urothelial carcinoma
por: Omura, Shota, et al.
Publicado: (2020)

Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma
por: Alhalabi, Omar, et al.
Publicado: (2021)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010)

Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer
por: Tanaka, N, et al.
Publicado: (2011)

Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade
por: Laverman, Gozewijn D., et al.
Publicado: (2011)

Retarding the progression of chronic kidney disease with renin angiotensin system blockade
por: Limesh, M., et al.
Publicado: (2012)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015)

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
por: Bloch, Michael J.
Publicado: (2020)

Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is There a Winner?
por: Lee, Hak Seung, et al.
Publicado: (2020)

Risk of lung cancer and renin–angiotensin blockade: a concise review
por: Rachow, Tobias, et al.
Publicado: (2020)

Role of the MUC1‐C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2020)

Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation
por: Aoki, Taro, et al.
Publicado: (2020)

Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System
por: Tanios, Bassem Y., et al.
Publicado: (2012)

Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics
por: Gismondi, Ronaldo Altenburg, et al.
Publicado: (2015)

The association of renin–angiotensin system blockades and pneumonia requiring admission in patients with COPD
por: Kim, Junghyun, et al.
Publicado: (2016)

Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection
por: Salah, Husam M., et al.
Publicado: (2020)

Effect of Renin-Angiotensin System Blockade on Mortality in Korean Hypertensive Patients with Proteinuria
por: Oh, Hyung Jung, et al.
Publicado: (2019)

IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
por: Shigeta, Keisuke, et al.
Publicado: (2023)

Management of Upper Tract Urothelial Carcinoma
por: Smith, Norm D.
Publicado: (2009)

Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer
por: Hagiwara, Masayuki, et al.
Publicado: (2018)

Urinary pH is an independent predictor of upper tract recurrence in non-muscle-invasive bladder cancer patients with a smoking history
por: Ide, Hiroki, et al.
Publicado: (2021)

NFATc1 Expression as a Prognosticator in Urothelial Carcinoma of the Upper Urinary Tract
por: Kawahara, Takashi, et al.
Publicado: (2017)

Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes
por: Silva, Mauro G., et al.
Publicado: (2022)

Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control
por: Harindhanavudhi, Tasma, et al.
Publicado: (2011)

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
por: Makani, Harikrishna, et al.
Publicado: (2013)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
por: Feng, Yan-Huan, et al.
Publicado: (2016)

Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy
por: Lennartz, David Paul, et al.
Publicado: (2020)

Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease
por: Han, Jin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t5pvb1te12mtm0tupe36hkquve